Lung Transplant Foundation
Lung transplantation (or ‘LTx’) presents very specific challenges, but the most daunting is a form of organ rejection called bronchiolitis obliterans syndrome (BOS). There are no effective treatments for BOS and lung transplant rejection.
The Lung Transplant Foundation is dedicated to funding research into this life-threating issue, educating and enhancing public awareness of organ donation, and promoting lung transplantation as a viable alternative to end-stage lung disease.
During the initial phase of the Jeff Goldstein BETTER program, the Foundation is facilitating deployment of 4DMedical’s XV LVAS imaging capability at up to eight lung transplant centres across the U.S. where its value in monitoring and enhancing transplant outcomes for patients with compromised pulmonary function will be assessed and reported.